Key Details
Price
$0.02Annual ROE
-479.24%Beta
0.84Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
30 Jan '23 Morgan Stanley
Underweight30 Jan '23 HC Wainwright & Co.
Buy22 Dec '22 Oppenheimer
Perform12 Sept '22 Morgan Stanley
Equal-Weight25 Aug '22 Alliance Global Partners
Buy23 Aug '22 Truist Securities
Hold22 June '22 HC Wainwright & Co.
Buy06 Apr '22 Truist Securities
Hold28 Jan '22 Oppenheimer
Outperform24 Nov '21 Morgan Stanley
Equal-WeightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Celularity doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Celularity?
- What is the ticker symbol for Celularity?
- Does Celularity pay dividends?
- What sector is Celularity in?
- What industry is Celularity in?
- What country is Celularity based in?
- When did Celularity go public?
- Is Celularity in the S&P 500?
- Is Celularity in the NASDAQ 100?
- Is Celularity in the Dow Jones?
- When does Celularity report earnings?
What is the primary business of Celularity?
Celularity is a biotechnology company focused on developing innovative cell therapies. They use placental-derived cells to create treatments for various diseases, including cancer and immune disorders. Their goal is to harness the power of the immune system to improve patient outcomes and enhance overall health.
What is the ticker symbol for Celularity?
The ticker symbol for Celularity is NASDAQ:CELUW
Does Celularity pay dividends?
No, Celularity does not pay dividends
What sector is Celularity in?
Celularity is in the Healthcare sector
What industry is Celularity in?
Celularity is in the Biotechnology industry
What country is Celularity based in?
Celularity is headquartered in United States
When did Celularity go public?
Celularity's initial public offering (IPO) was on 19 July 2021
Is Celularity in the S&P 500?
No, Celularity is not included in the S&P 500 index
Is Celularity in the NASDAQ 100?
No, Celularity is not included in the NASDAQ 100 index
Is Celularity in the Dow Jones?
No, Celularity is not included in the Dow Jones index
When does Celularity report earnings?
The date for Celularity's next earnings report has not been announced yet